Clinical Trial Update: Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of JMKX003002 in end-stage renal disease patients on hemodialysis with hyperphosphatemia, and the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• JMKX003002

Snippet

Sponsor: Jemincare | Conditions: Hyperphosphatemia | Phase 2 | Status: RECRUITING